The Mount Sinai Hospital has performed New York City's first procedure using the HYDROS Robotic System, a cutting-edge technology designed to treat benign prostatic hyperplasia (BPH), or an enlarged ...

The Mount Sinai Hospital has performed New York City's first procedure using the HYDROS™ Robotic System, a cutting-edge ...

This new union of the two “off-label” drugs – gemcitabine and docetaxel – was offered from October ... Docetaxel is used to treat advanced or metastatic breast, head and neck, stomach, prostate and ...

This new union of the two “off-label” drugs – gemcitabine and docetaxel ... head and neck, stomach, prostate and non-small cell lung cancers. Dr Tan Yu Guang, an associate consultant ...

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today. From reproductive rights to climate change to Big Tech, The ...

a hit to his reputation and a decrease in his brand's value before his contract renegotiation with the record label this year. The suit added that UMG "understood the recording's inflammatory and ...

FORT WAYNE, Ind. (WANE) — After being arrested in connection to a fatal stabbing at Promenade Park, 23-year-old Lamont Cooley reportedly admitted to the act and said he was trying to protect a ...

Jan. 15, 2025 – Prostate cancer is quite common – over 60% of those diagnosed are men over the age of 65 – but it’s not a high priority for cancer researchers. One big reason ...

But after a couple of years of work, xMEMS has arrived at the next generation — ultrasound through a solid-state speaker. This tiny, 1mm-thin speaker is called Cypress, and after listening to it ...

NEW YORK, Jan 15 (Reuters) - Drake sued his longtime label on Wednesday, accusing Universal Music Group of defamation for promoting Kendrick Lamar's "Not Like Us," saying the song's false ...

Howard R. Soule, Ph.D., executive vice president and chief science officer of the Prostate Cancer Foundation, said, "These findings fill a therapeutic gap for patients with advanced prostate cancer.